Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHutchmed Share News (HCM)

Share Price Information for Hutchmed (HCM)

Share Price is delayed by 15 minutes
Get Live Data
160.00    -1.25 (-0.78%)
Bid:
157.50
Ask:
160.00
Spread: 2.50 (1.587%)
Market Cap: £1.38b
HCM Live PriceLast checked at - London Stock Exchange

Intraday Hutchmed Share Chart

Thursday broker round-up UPDATE

Thu, 29th Nov 2012 07:27
Aberdeen Asset Management: Morgan Stanley raises target price from 365p to 375p; keeping an overweight rating.ASOS: Societe Generale raises target price from 2500p to 2530p and reiterates its hold recommendation.Babcock International: UBS downgrades from buy to neutral.Barratt Developments: HSBC raises target price from 170p to 241p; overweight rating kept.Bellway: HSBC raises target price from 950p to 1259p; overweight rating reiterated.Berkeley Group: HSBC raises target price from 1560p to 2010p, while maintaining an overweight rating.Betfair: Nomura reduces target price from 946p to 890p; buy rating unchanged.Bovis Homes Group: HSBC raises target price from 575p to 753p; overweight rating kept.British Sky Broadcasting Group: Jefferies reduces target price from 700p to 650p and downgrades from hold to underperform.Chemring Group: Espirito Santo cuts target price from 350p to 320p, while reiterating a buy recommendation.Cineworld Group: Canaccord Genuity raises target price from 280p to 350p and maintains its buy recommendation.Clarkson: JP Morgan reduces target price from 1450p to 1400p and reiterates an overweight rating.Dixons Retail: Panmure Gordon raises target price from 28p to 32p and reiterates its buy recommendation. Seymour Pierce raises target price from 26p to 34p and maintains a buy rating.Greencore: Panmure Gordon raises target price from 95p to 100p; buy rating unchanged.Highland Gold Mining: Westhouse Securities initiates with a target price of 160p and a buy recommendation.Hutchison China Meditech: UBS raises target price from 470p to 520p and reiterates its buy recommendation.Imagination Technologies: Jefferies reduces target price from 724p to 628p; buy recommendation kept. UBS upgrades from sell to neutral.Invensys: Nomura raises target price from 330p to 370p; buy rating reiterated. Barclays Capital raises target price from 235p to 385p and upgrades to overweight. Deutsche Bank raises target price from 230p to 295p and keeps its hold recommendation. Bank of America upgrades to buy with a target price of 275p. Societe Generale raises target price from 215p to 330p, while keeping a hold recommendation.Kenmare Resources: JP Morgan moves target price from 41p to 40p, while maintaining its neutral rating.Man Group: Morgan Stanley reduces target price from 80p to 73p; equal weight rating remains unchanged.Marston's: Panmure Gordon raises target price from 130p to 135p and maintains a buy recommendation.Mitchells&Butlers: Nomura raises target price from 300p to 322p and downgrades from buy to neutral.Persimmon: HSBC raises target price from 755p to 957p and upgrades to overweight.Petropavlovsk: Westhouse Securities starts with a target price of 470p and a buy recommendation.Pheonix IT: Panmure Gordon reduces target price from 173p to 160p; buy recommendation remains unchanged.Premier Farnell: Deutsche Bank cuts target price from 211p to 200p, while maintaining a buy recommendation.Randgold Resources: Bank of America downgrades from buy to neutral.Redrow: HSBC raises target price from 165p to 198p and reiterates an overweight rating.RPC Group: Panmure Gordon raises target price from 473p to 491p and keeps its buy recommendation.Severn Trent: RBC upgrades to sector perform. Smith&Nephew: HB Markets downgrades to hold.Taylor Wimpey: HSBC raises target price from 57p to 82p and keeps an overweight rating.Thomas Cook Group: UBS moves target price from 17p to 24p; neutral rating kept.United Utilities: Nomura downgrades from buy to neutral. Barclays Capital reduces target price from 665p to 700p and upgrades to equal weight. HB Markets downgrades to hold.Victrex: UBS moves target price from 1350p to 1620p, while keeping a neutral rating.William Hill: Nomura raises target price from 215p to 260p and maintains a reduce recommendation.

Related News

LONDON MARKET CLOSE: European stocks climb as Dow Jones hits new high
11 hours ago

LONDON MARKET CLOSE: European stocks climb as Dow Jones hits new high

(Alliance News) - The FTSE 100 made strong progress on Thursday amid an improving outlook for inflation following this week's drop in oil prices and a...

Deutsche Bank downgrades Man Group, says stock up with events
15 hours ago

Deutsche Bank downgrades Man Group, says stock up with events

(Sharecast News) - Deutsche Bank downgraded Man Group to 'hold' from 'buy' on Thursday as it said the stock was now up with events.

Hutchmed China reports positive phase two fanregratinib study data
16 hours ago

Hutchmed China reports positive phase two fanregratinib study data

(Alliance News) - Hutchmed China Ltd on Thursday reported positive phase two data for fanregratinib in patients with intrahepatic cholangiocarcinoma, ...

Hutchmed News

Hutchmed China reports positive phase two fanregratinib study data
16 hours ago

Hutchmed China reports positive phase two fanregratinib study data

(Alliance News) - Hutchmed China Ltd on Thursday reported positive phase two data for fanregratinib in patients with intrahepatic cholangiocarcinoma, ...

Hutchmed highlights data for sovleplenib in rare blood disorder
12 Jun 2026

Hutchmed highlights data for sovleplenib in rare blood disorder

(Alliance News) - Hutchmed China Ltd on Friday said phase III trial results for its investigational drug sovleplenib showed significant efficacy and a...

TRADING UPDATES: Tungsten secures loan; Ashtead trading in line
21 May 2026

TRADING UPDATES: Tungsten secures loan; Ashtead trading in line

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

EARNINGS AND TRADING: AltynGold reports annual revenue surge
29 Apr 2026

EARNINGS AND TRADING: AltynGold reports annual revenue surge

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately repor...

Hutchmed begins phase-three trials of lymphoma therapy in China
23 Mar 2026

Hutchmed begins phase-three trials of lymphoma therapy in China

(Alliance News) - Hutchmed China Ltd on Monday said it had begun phase-three clinical trials of its lymphoma treatment in China.

LONDON BRIEFING: GSK gains Japan nod; Anglo to delist shares in Zurich
23 Mar 2026

LONDON BRIEFING: GSK gains Japan nod; Anglo to delist shares in Zurich

(Alliance News) - GSK makes regulatory progress in Japan for a cancer therapy, Anglo American moves to delist from the Swiss exchange as part of its r...

Hutchmed shares slide as recalls cancer treatment Tazverik
9 Mar 2026

Hutchmed shares slide as recalls cancer treatment Tazverik

(Alliance News) - Hutchmed China Ltd on Monday saw its shares fall after reporting the withdrawal of a cancer medication which it licenses from Ipsen ...